ezogabine has been researched along with cysteine in 1 studies
| Studies (ezogabine) | Trials (ezogabine) | Recent Studies (post-2010) (ezogabine) | Studies (cysteine) | Trials (cysteine) | Recent Studies (post-2010) (cysteine) |
|---|---|---|---|---|---|
| 383 | 26 | 241 | 40,132 | 418 | 11,457 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gamper, N; Gigout, S; Ooi, L; Pettinger, L | 1 |
1 other study(ies) available for ezogabine and cysteine
| Article | Year |
|---|---|
Triple cysteine module within M-type K+ channels mediates reciprocal channel modulation by nitric oxide and reactive oxygen species.
Topics: Action Potentials; Aniline Compounds; Animals; Animals, Newborn; Anthracenes; Benzoates; Biotin; Calcitonin Gene-Related Peptide; Carbamates; Cells, Cultured; Cysteine; Enzyme Inhibitors; Female; Humans; Imidazoles; KCNQ Potassium Channels; Male; Membrane Transport Modulators; Models, Molecular; Mutation; Neurons; Nitric Oxide; Nitric Oxide Donors; Patch-Clamp Techniques; Phenylenediamines; Potassium Channel Blockers; Rats; Reactive Oxygen Species; S-Nitroso-N-Acetylpenicillamine; Transfection; Trigeminal Ganglion | 2013 |